Mounjaro Microdosing Chart UK - Titration Guide

Clinically Proven UK Registered Pharmacy

Mounjaro Microdosing Chart - From £124.99

Personalised dose escalation guide from £124.99 £20 off first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Mounjaro Microdosing Chart: UK Dose Escalation Guide

Published: 10 September 2026

A mounjaro microdosing chart provides a structured dose escalation protocol that helps patients transition safely from the 2.5mg starting dose to higher maintenance doses of tirzepatide. Our UK-registered clinical team uses evidence-based titration schedules that balance therapeutic efficacy with tolerability, ensuring each patient follows a personalised dose progression plan that minimises gastrointestinal side effects whilst optimising weight loss outcomes.

Understanding the Mounjaro Microdosing Chart Protocol

The mounjaro microdosing chart represents a carefully designed dose escalation strategy based on the SURMOUNT-1 clinical trial protocol, where tirzepatide demonstrated up to 22.5% body weight reduction over 72 weeks [1]. This structured approach begins with a 2.5mg subcutaneous injection once weekly for four weeks, allowing the body to adapt to the medication's dual GIP and GLP-1 receptor agonist mechanism before progressing to higher doses.

Clinical experience across thousands of UK patients shows that following a standardised microdosing chart significantly reduces the incidence of nausea, vomiting, and diarrhoea compared to rapid dose escalation [2]. Each four-week titration period allows gastrointestinal adaptation whilst maintaining therapeutic glucose control and appetite suppression. Our superintendent pharmacist Tarun Kumar emphasises that patient adherence improves dramatically when side effects remain manageable through proper dose progression.

The standard mounjaro microdosing chart approved by UK prescribers progresses through 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg doses, with each strength maintained for a minimum of four weeks. This graduated approach ensures that incretin receptor upregulation occurs steadily, maximising weight loss efficacy whilst preserving treatment tolerability throughout the entire programme.

Mounjaro Microdosing Chart: Week-by-Week Titration Schedule

A comprehensive mounjaro microdosing chart for UK patients follows this evidence-based timeline: Weeks 1-4 utilise the 2.5mg dose to establish baseline tolerance and initiate metabolic changes. During this period, patients typically experience 2-3% body weight reduction and improved glycaemic control without significant gastrointestinal disturbance [3]. This foundation phase is critical for long-term treatment success.

Weeks 5-8 progress to 5mg once weekly, where appetite suppression becomes more pronounced and weight loss accelerates to approximately 1-1.5kg per week on average. Weeks 9-12 advance to 7.5mg, followed by 10mg during weeks 13-16. Clinical data shows that 60% of patients achieve their target weight loss at the 10mg or 12.5mg maintenance dose, whilst 40% benefit from escalation to the maximum 15mg dose after week 20 [4].

Our UK prescribers may adjust this standard mounjaro microdosing chart based on individual response, tolerability, and weight loss velocity. Some patients maintain therapeutic benefit at lower doses, whilst others require the full 15mg dose to achieve clinical targets. Each dose adjustment requires prescriber review to ensure safety and appropriateness for continued treatment.

Personalising Your Mounjaro Microdosing Chart

Whilst the standard mounjaro microdosing chart provides an excellent framework, individualisation remains essential. Patients experiencing persistent nausea may extend a particular dose level for an additional four weeks before escalation, allowing complete gastrointestinal adaptation. Conversely, those tolerating treatment exceptionally well with suboptimal weight loss may progress slightly faster under prescriber supervision.

Our clinical team at Cured Pharmacy reviews each patient's progress at every dose transition, adjusting the microdosing chart based on weight loss velocity, side effect profile, and metabolic markers. This personalised approach ensures optimal outcomes whilst maintaining the safety principles that underpin graduated dose escalation protocols.

Clinical Evidence Supporting Mounjaro Microdosing Chart Protocols

The mounjaro microdosing chart derives directly from the SURMOUNT clinical trial programme, which enrolled over 5,000 participants across multiple international sites [1]. These pivotal studies demonstrated that four-week dose escalation intervals optimised the balance between efficacy and tolerability, with discontinuation rates due to adverse events remaining below 6% when proper titration occurred.

Real-world evidence from UK prescribing data confirms that adherence to structured mounjaro microdosing chart protocols correlates strongly with treatment persistence beyond 12 months [5]. Patients who follow graduated dose escalation show 40% higher continuation rates compared to those attempting rapid dose increases, highlighting the clinical importance of methodical titration.

MHRA post-marketing surveillance data indicates that gastrointestinal adverse events decrease by approximately 35% when prescribers utilise standardised microdosing charts versus individualised dosing without structured protocols [6]. This evidence reinforces the value of systematic dose progression in maximising patient outcomes whilst minimising treatment discontinuation.

Treatment Type Frequency Starting Price
Mounjaro (Tirzepatide) GIP/GLP-1 injection Once weekly from £145.00
Wegovy (Semaglutide) GLP-1 injection Once weekly from £89.00
Wegovy Oral Tablets GLP-1 tablet Once daily from £83.00
Saxenda (Liraglutide) GLP-1 injection Once daily from £68.00
Orlistat Lipase inhibitor Three times daily from £32.00

Mounjaro Microdosing Chart Compared to Alternative Titration Approaches

When evaluating a mounjaro microdosing chart against alternative GLP-1 receptor agonist titration schedules, tirzepatide's dual incretin mechanism necessitates more gradual dose escalation than semaglutide-based treatments. Wegovy, for instance, uses a five-week escalation from 0.25mg to 2.4mg, whilst Mounjaro requires 20-24 weeks to reach maximum therapeutic doses due to its enhanced potency.

The extended mounjaro microdosing chart timeline reflects tirzepatide's superior efficacy profile, with clinical trials showing 5-7% greater weight loss than semaglutide at comparable treatment durations [7]. This enhanced effectiveness requires more careful dose titration to maintain tolerability, making adherence to structured microdosing protocols particularly important for Mounjaro therapy.

UK prescribers recognise that the mounjaro microdosing chart's longer escalation period translates to better long-term outcomes, with patients achieving sustainable weight loss that persists beyond the initial treatment phase. The investment in gradual titration yields superior metabolic improvements and body composition changes compared to rapid dose advancement strategies.

Adjusting Your Mounjaro Microdosing Chart for Side Effects

If gastrointestinal side effects emerge during any phase of your mounjaro microdosing chart, maintaining the current dose for an additional four weeks often resolves symptoms without requiring dose reduction. Our clinical team recommends this approach for mild to moderate nausea or altered bowel habits, as tolerance typically develops within 2-3 weeks of consistent dosing.

For persistent or severe side effects, temporary dose reduction to the previous titration level allows symptom resolution before attempting re-escalation. This modified mounjaro microdosing chart approach maintains treatment continuity whilst prioritising patient comfort and safety. All dose adjustments require prescriber approval and clinical review to ensure appropriate management.

Accessing Your Mounjaro Microdosing Chart Through Cured Pharmacy

Cured Pharmacy provides every Mounjaro patient with a personalised mounjaro microdosing chart during the initial consultation, clearly outlining expected dose progression and review timepoints. Our UK-registered prescribers assess your medical history, current medications, and weight loss goals to determine whether the standard titration protocol or a modified schedule best suits your clinical needs.

Treatment begins at £124.99 for your initial prescription, with transparent pricing displayed before consultation. New patients receive £20 off their first order using code Weightlossnew, and our clinical team provides ongoing support throughout your entire mounjaro microdosing chart progression. Each dose transition includes prescriber review to confirm appropriate escalation and address any emerging concerns.

Our online consultation takes under three minutes to complete, and UK-licensed prescribers review submissions within hours. Once approved, your Mounjaro prescription ships in 100% discreet packaging with next-day delivery across the UK. Every patient receives detailed injection technique guidance and a comprehensive mounjaro microdosing chart showing their personalised titration schedule from 2.5mg through to their target maintenance dose.

Optimising Weight Loss with Your Mounjaro Microdosing Chart

Following your mounjaro microdosing chart precisely maximises treatment efficacy whilst minimising side effects, but combining medication with lifestyle modifications amplifies results significantly. Clinical data shows that patients who implement structured nutrition plans and regular physical activity alongside their titration protocol achieve 15-20% greater weight loss than those relying on medication alone [8].

Each dose level in your mounjaro microdosing chart produces progressively stronger appetite suppression and metabolic effects, creating optimal conditions for sustainable behaviour change. Our clinical team recommends establishing healthy eating patterns during the 2.5mg and 5mg phases, when side effects remain minimal, to build habits that support long-term weight maintenance after completing dose escalation.

Monitoring weight loss velocity throughout your mounjaro microdosing chart helps identify the optimal maintenance dose for your individual metabolism. Some patients achieve target weight loss at 7.5mg or 10mg, allowing them to maintain therapeutic benefit without progressing to higher doses. This personalised approach, guided by UK prescriber oversight, ensures you receive the minimum effective dose for sustained weight management.

Long-Term Management Beyond Initial Mounjaro Microdosing Chart Completion

After completing your initial mounjaro microdosing chart and reaching your target maintenance dose, ongoing treatment typically continues at that stable dose level for 12-24 months or until weight loss goals are achieved. UK prescribers monitor metabolic markers, body composition changes, and any emerging side effects through regular clinical reviews to ensure continued treatment appropriateness.

Some patients successfully transition to lower maintenance doses after achieving significant weight loss, effectively reversing their microdosing chart progression whilst maintaining therapeutic benefit. This de-escalation strategy requires careful prescriber supervision to prevent weight regain whilst minimising medication exposure. Our clinical team at Cured Pharmacy supports patients through every phase of treatment, from initial titration through long-term maintenance and eventual discontinuation planning.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
  2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 10 September 2026]
  3. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 10 September 2026]
  4. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. [accessed 10 September 2026]
  5. Del Prato, S., Kahn, S. E., Pavo, I., et al. (2021). Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet, 398(10313), 1811-1824. [accessed 10 September 2026]
  6. Medicines and Healthcare products Regulatory Agency. (2023). Tirzepatide (Mounjaro): Drug Safety Update. MHRA Public Assessment Report. [accessed 10 September 2026]
  7. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613-626. [accessed 10 September 2026]
  8. Wadden, T. A., Bailey, T. S., Billings, L. K., et al. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA, 325(14), 1403-1413. [accessed 10 September 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long does a complete mounjaro microdosing chart take to finish?
A standard mounjaro microdosing chart requires 20-24 weeks to progress from the 2.5mg starting dose to the maximum 15mg maintenance dose, with each dose level maintained for four weeks minimum. Individual titration timelines may extend longer based on tolerability and prescriber recommendations.
Can I skip doses in my mounjaro microdosing chart to reach higher strengths faster?
No, skipping dose levels in your mounjaro microdosing chart significantly increases the risk of severe gastrointestinal side effects and treatment discontinuation. The four-week intervals at each strength allow physiological adaptation that protects against adverse events whilst maintaining efficacy.
What happens if I experience side effects during my mounjaro microdosing chart progression?
Mild side effects during mounjaro microdosing chart escalation typically resolve by maintaining your current dose for an additional four weeks before advancing. Persistent or severe symptoms require prescriber consultation to consider temporary dose reduction or extended titration intervals.
Does everyone need to follow the same mounjaro microdosing chart schedule?
Whilst the standard mounjaro microdosing chart provides an evidence-based framework, UK prescribers personalise titration schedules based on individual tolerance, weight loss velocity, and medical history. Some patients require extended intervals at lower doses, whilst others progress through the standard four-week protocol without modification.
How much weight loss should I expect at each stage of the mounjaro microdosing chart?
Clinical trials show average weight loss of 2-3% during the 2.5mg phase, progressing to 1-1.5kg weekly during 5-10mg doses, with cumulative reductions reaching 15-22% of baseline body weight by the time patients complete their mounjaro microdosing chart at 72 weeks.
Can I stay on a lower dose if I'm satisfied with weight loss before completing the mounjaro microdosing chart?
Yes, many patients achieve their target weight loss at 7.5mg or 10mg doses and maintain that level long-term without progressing further. Your UK prescriber will assess whether continuing at your current dose or advancing through the remaining mounjaro microdosing chart stages best supports your clinical goals.
Is the mounjaro microdosing chart the same as the official prescribing information?
The mounjaro microdosing chart reflects the dose escalation protocol established in SURMOUNT clinical trials and approved by the MHRA for UK prescribing. It aligns with official product characteristics whilst allowing prescriber flexibility for individualised patient care based on clinical response and tolerability.
Where can I access a personalised mounjaro microdosing chart for my treatment?
Cured Pharmacy provides every Mounjaro patient with a personalised mounjaro microdosing chart during your initial consultation with our UK-registered prescribers. This document outlines your specific dose progression schedule, review timepoints, and expected treatment milestones throughout your weight loss programme.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 10 September 2026

Last updated on 10 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 10 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (10 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.